Profile data is unavailable for this security.
About the company
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.
- Revenue in CAD (TTM)1.04m
- Net income in CAD-4.43m
- Incorporated1989
- Employees0.00
- LocationTheralase Technologies Inc41 Hollinger RoadTORONTO M4B 3G4CanadaCAN
- Phone+1 (416) 699-5273
- Fax+1 (416) 699-5250
- Websitehttps://theralase.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NuGen Medical Devices Inc | 354.42k | -9.08m | 21.64m | 12.00 | -- | -- | -- | 61.06 | -0.0488 | -0.0488 | 0.0019 | -0.0139 | 0.0499 | 1.40 | 29.80 | -- | -127.90 | -- | -240.95 | -- | 49.09 | -- | -2,561.29 | -- | 0.203 | -6.25 | 1.58 | -- | 117.51 | -- | -67.84 | -- | -- | -- |
Aurora Spine Corp | 21.35m | -1.76m | 21.87m | 13.00 | -- | 3.17 | -- | 1.02 | -0.0244 | -0.0244 | 0.2935 | 0.0898 | 1.42 | 1.92 | 4.09 | -- | -11.69 | -16.00 | -16.45 | -22.23 | 58.86 | 46.65 | -8.25 | -11.76 | 1.39 | -5.80 | 0.4195 | -- | -2.40 | 10.83 | -11.93 | -- | 10.36 | -- |
Perimeter Medical Imaging AI Inc | 536.70k | -17.68m | 26.60m | -- | -- | 1.53 | -- | 49.57 | -0.2734 | -0.2734 | 0.0083 | 0.2674 | 0.0168 | 2.88 | 5.06 | -- | -55.33 | -64.55 | -70.91 | -81.45 | 47.47 | -- | -3,293.39 | -7,957.25 | 4.03 | -- | 0.0139 | -- | 203.93 | -- | -41.69 | -- | -- | -- |
VentriPoint Diagnostics Ltd. | 45.29k | -4.72m | 29.08m | -- | -- | -- | -- | 642.06 | -0.0301 | -0.0301 | 0.0003 | -0.0059 | 0.0159 | -- | 0.2115 | -- | -165.25 | -105.23 | -305.80 | -178.01 | 85.10 | 67.16 | -10,412.98 | -8,020.43 | -- | -136.46 | -- | -- | -27.86 | -3.96 | 0.0177 | -- | -- | -- |
Therma Bright Inc | 25.85k | -2.62m | 29.44m | -- | -- | 14.63 | -- | 1,139.00 | -0.0101 | -0.0101 | 0.00009 | 0.0048 | 0.0076 | 0.0023 | 0.0960 | -- | -77.19 | -220.66 | -172.38 | -444.57 | 98.45 | -- | -10,145.96 | -10,853.16 | 0.0422 | -254.56 | 0.0456 | -- | -82.86 | 11.13 | 35.93 | -- | 40.15 | -- |
Enablence Technologies Inc | 2.01m | -15.31m | 33.47m | 202.00 | -- | -- | -- | 16.61 | -0.8237 | -0.8237 | 0.1084 | -1.48 | 0.7554 | 8.16 | 6.81 | -- | -574.25 | -191.45 | -- | -- | -146.33 | -61.64 | -760.20 | -250.29 | 0.1519 | -2.88 | -- | -- | -0.8595 | -10.36 | -173.59 | -- | 5.99 | -- |
Theralase Technologies Inc | 1.04m | -4.43m | 40.17m | 0.00 | -- | 20.87 | -- | 38.67 | -0.0199 | -0.0199 | 0.0047 | 0.0086 | 0.3222 | 0.8483 | 3.66 | -- | -137.39 | -69.79 | -198.84 | -81.78 | 51.19 | 37.49 | -426.36 | -557.68 | 0.9119 | -- | 0.156 | -- | -6.00 | -9.20 | 12.69 | -- | -22.53 | -- |
Nanalysis Scientific Corp | 34.95m | -14.76m | 44.11m | 130.00 | -- | 1.71 | -- | 1.26 | -0.1457 | -0.1457 | 0.3519 | 0.228 | 0.5745 | 4.25 | 5.14 | 268,876.90 | -24.63 | -18.30 | -36.68 | -25.35 | 18.23 | 42.75 | -42.87 | -39.01 | 1.11 | -2.27 | 0.4119 | -- | 14.69 | 27.71 | -63.35 | -- | 15.35 | -- |